American Origin Unverified
This profile is unclaimed and has not been independently reviewed.
Claim & get verified
China SXT Pharmaceuticals, Inc.
$6.4MMarket cap
$1.9MRevenue · FY2024
-$3.3MNet income
75Employees
SXTCNASDAQ
2019IPO
About China SXT Pharmaceuticals, Inc.
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Reported figures
Financial summary
- Revenue FY2024
- $1.9M
- Net income
- -$3.3M
- Total assets
- $21.7M
- Market cap
- $6.4M
Source: SEC EDGAR · updated Jun 7, 2026
- Market cap
- $6.4M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Jan 4, 2019
Market data by Polygon.io · prices are 15-minute delayed
No reviews yet. Be the first to review China SXT Pharmaceuticals, Inc..
Write a review
Explore
Browse all →
